NCT03558217 is a NA clinical trial of Collared Femoral Implant in Hip Osteoarthritis, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What drugs are being tested in NCT03558217?

Interventions in NCT03558217: Collared Femoral Implant, Collarless Femoral Implant.

What condition does NCT03558217 study?

NCT03558217 studies Hip Osteoarthritis, Hip Arthroplasty.

Is NCT03558217 still recruiting?

NCT03558217 is currently completed. Last updated 4 February 2022.

Last reviewed 2022-02-04 · How we verify

NCT03558217

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Collared Versus Collarless Femoral Implants for Total Hip Arthroplasty

Completed NA Last updated 4 February 2022

What this trial tests

NA trial testing Collared Femoral Implant in Hip Osteoarthritis in 96 participants. Completed in 31 October 2021.

Timeline

15 January 2018

Primary endpoint
31 October 2021

31 October 2021

Quick facts

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	96
Start date	15 January 2018
Primary completion	31 October 2021
Estimated completion	31 October 2021
Sites	1 location across Canada

Drugs / interventions tested

Collared Femoral Implant
Collarless Femoral Implant

Conditions studied

Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
Hip Arthroplasty — all drugs for Hip Arthroplasty →

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

18 and older, any sex, with Hip Osteoarthritis or Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized control trial that will investigate whether a collared hip replacement implant provides greater stability compared to a collarless option. Stability will be measured by implant migration with radiostereometric analysis (RSA) imaging. Secondary objectives will be to compare function, quality of life and cost between the two implant types. We will also compare between two different surgical approaches, the direct anterior and direct lateral.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Femoral stem migration after direct lateral and direct anterior total hip arthroplasty: a prospective cohort study.
Polus JS, Perelgut ME, Vasarhelyi EM, Teeter MG, et al · · 2022 · cited 8× · PMID 35926882 · DOI 10.1503/cjs.013221
Acetabular cup fixation with and without screws following primary total hip arthroplasty: migration evaluated by radiostereometric analysis.
Polus JS, Vasarhelyi EM, Lanting BA, Teeter MG. · · 2024 · cited 5× · PMID 37016808 · DOI 10.1177/11207000231164711

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
NCT07327931 — PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults · NA · recruiting
NCT07288983 — PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery · NA · recruiting
NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
NCT07347041 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) · NA · recruiting

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03558217 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last refreshed: 4 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03558217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing